Provided By PR Newswire
Last update: Dec 11, 2025
NEW YORK, Dec. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read more at prnewswire.comNASDAQ:AVXL (12/23/2025, 11:25:48 AM)
3.6901
-0.06 (-1.6%)
Find more stocks in the Stock Screener


